INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $126,000 | -43.0% | 27,351 | +24.7% | 0.00% | – |
| Q3 2018 | $221,000 | +54.5% | 21,940 | +10.7% | 0.00% | – |
| Q2 2018 | $143,000 | +21.2% | 19,811 | +1.6% | 0.00% | – |
| Q1 2018 | $118,000 | -30.6% | 19,493 | +10.3% | 0.00% | – |
| Q4 2017 | $170,000 | -60.1% | 17,678 | -47.6% | 0.00% | -100.0% |
| Q2 2017 | $426,000 | +57.8% | 33,712 | +31.1% | 0.00% | – |
| Q1 2017 | $270,000 | +53.4% | 25,712 | +34.5% | 0.00% | – |
| Q4 2016 | $176,000 | +20.5% | 19,112 | +54.2% | 0.00% | – |
| Q3 2016 | $146,000 | -25.9% | 12,394 | -18.4% | 0.00% | – |
| Q2 2016 | $197,000 | -4.4% | 15,197 | +18.1% | 0.00% | – |
| Q1 2016 | $206,000 | -83.1% | 12,869 | -69.7% | 0.00% | -100.0% |
| Q4 2015 | $1,216,000 | – | 42,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
| Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
| Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
| SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
| Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
| JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
| TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
| GAM Holding AG | 83,940 | $745,000 | 0.03% |
| Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |